Chunghwa Chemical Synthesis & Biotech is a Pharmaceutical company, CMO/CDMO company operating in the pharmaceutical industry.
Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB), founded in 1964, is one of the largest API manufacturers in Taiwan. CCSB is a FDA /EU approved cGMP API plant to produce synthesis and biotechnology products. CCSB has filed US DMF, EDMF and COS for several products. Our products include Mycophenolate Mofetil, Rapamycin (Sirolimus), Tacrolimus Monohydrate, Everolimus, Caspofungin Acetate , etc. CCSB also offers contract manufacturing in the cGMP plants.
Company type
Pharmaceutical company, CMO/CDMO
Products and services
APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Geographies they support
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Chunghwa Chemical Synthesis & Biotech, 1 Tung-Hsing Street, Shu-Lin Dist., New Taipei City, , Taiwan, China, 23850
